Medicines |
rifaximin |
2 weeks of treatment provides significant relief from IBS symptoms, bloating, abdominal pain and loose or watery stools |
97 |
|
loperamide |
For first-line treatment of IBS-D diarrhea |
98 |
|
Bile acid sequestrants |
Improves stool consistency and reduces bowel movement frequency |
99 |
|
antispasmodic |
It is very effective for abdominal pain in patients with IBS, but can lead to more adverse effects such as dry mouth, vertigo, and constipation |
100 |
|
peppermint oil |
Superior to placebo in the treatment of IBS, but adverse events are more frequent and the quality of evidence is very low |
101 |
|
antidepressant |
Antidepressant medications provide better relief for IBS. However, there are limitations in the information, so estimates of efficacy may be overestimated |
102 |
|
pregabalin |
In patients with allergic IBS, it can significantly increase their rectal sensory threshold to a dilated state |
103 |
Diet |
FODMAP diet |
Effective for many patients, but not for all due to complexity of operation |
104–106 |
|
Increased Dietary Fiber |
The clinical symptoms of IBS were only marginally improved and the beneficial effects were limited to psyllium seeds, while bran had no significant effect on them |
107 |
|
Gluten-free Diet (GFD) |
GFD was associated with overall symptom improvement compared with controls, but there was insufficient evidence to confirm that GFD improved IBS symptoms |
108 |
Gut microbiota |
probiotics |
Reduces pain and symptom severity scores |
109,110 |
Synergistic combination of prebiotics and probiotics (called synbiotics) |
Beneficial for overall IBS symptoms and abdominal pain, but unable to draw definitive conclusions about its efficacy |
111,112 |
Fecal microbiota transplantation |
Recommended for the treatment of recurrent C. difficile infections accompanying IBD, but very time-consuming and labor-intensive |
113–116 |
complementary alternative therapy |
hypnotherapy |
Applications are limited by considerable cost and long duration as well as adverse patient and clinician restrictions |
117,118 |
acupuncture |
It may be possible to improve intestinal motility and visceral sensitivity to IBS treatment by modulating brain gut peptide levels in the central nervous system, intestines, and blood. However, the reasons for the effectiveness of acupuncture treatment still need to be further explored |
119–123 |
Psychotherapeutic Approaches |
cognitive behavioral therapy (CBT) |
Patients with IBS develop positive clinical symptoms after treatment, which may be related to their brain network function, altered structural connectivity, and altered gut microbiome. However, there is a lack of reference for evaluating microbiome persistence and neuroanatomical alterations in CBT-responsive populations |
124 |